These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The bumpy road to polio eradication. Modlin JF N Engl J Med; 2010 Jun; 362(25):2346-9. PubMed ID: 20573922 [No Abstract] [Full Text] [Related]
27. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively? Ogra PL Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881 [TBL] [Abstract][Full Text] [Related]
28. Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP). Alexander L; Birkhead G; Guerra F; Helms C; Hinman A; Katz S; LeBaron CW; Modlin J; Murphy TV; ; Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1106-12. PubMed ID: 15583093 [TBL] [Abstract][Full Text] [Related]
29. Epidemiology of poliomyelitis--options and update. Dutta A Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232 [TBL] [Abstract][Full Text] [Related]
30. Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa. Schoub BD Vaccine; 2012 Sep; 30 Suppl 3():C35-7. PubMed ID: 22939019 [TBL] [Abstract][Full Text] [Related]
31. [On the viability of introducing the inactivated polio vaccine in Colombia]. Alvarez FP; Mojica JA; Espinal C; Debbag R Rev Panam Salud Publica; 2011 May; 29(5):383-4; author reply 384-6. PubMed ID: 21709946 [No Abstract] [Full Text] [Related]
33. [Worldwide eradication of poliomyelitis]. Rasch G; Schreier E; Kiehl W; Kurth R Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120 [TBL] [Abstract][Full Text] [Related]
34. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708 [TBL] [Abstract][Full Text] [Related]
35. Strengths and weaknesses of current polio vaccines--a view from industry. André FE Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338 [TBL] [Abstract][Full Text] [Related]
36. Safety of oral poliomyelitis vaccine: results of a WHO enquiry. Esteves K Bull World Health Organ; 1988; 66(6):739-46. PubMed ID: 3266113 [TBL] [Abstract][Full Text] [Related]
37. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever. Orenstein WA; Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328 [TBL] [Abstract][Full Text] [Related]
38. Polio eradication. Rethinking the polio endgame. Roberts L Science; 2009 Feb; 323(5915):705. PubMed ID: 19197036 [No Abstract] [Full Text] [Related]
39. [The perspective of global eradication of poliomyelitis]. Knolle H; Egli A; Candrian U Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784 [TBL] [Abstract][Full Text] [Related]
40. Progress toward global eradication of poliomyelitis, 1988-1993. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(27):499-503. PubMed ID: 7517494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]